112 related articles for article (PubMed ID: 38030079)
61. The efficacy of induction chemotherapy in the treatment of stage II nasopharyngeal carcinoma in intensity modulated radiotherapy era.
Li PJ; Mo HY; Luo DH; Hu WH; Jin T
Oral Oncol; 2018 Oct; 85():95-100. PubMed ID: 30220326
[TBL] [Abstract][Full Text] [Related]
62. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.
Sommat K; Hussain A; Ong WS; Yit NLF; Khoo JBK; Soong YL; Wee JTS; Fong KW; Tan TWK
Radiother Oncol; 2019 Sep; 138():149-157. PubMed ID: 31265972
[TBL] [Abstract][Full Text] [Related]
63. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
[TBL] [Abstract][Full Text] [Related]
64. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
McDowell LJ; Rock K; Xu W; Chan B; Waldron J; Lu L; Ezzat S; Pothier D; Bernstein LJ; So N; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):340-352. PubMed ID: 30191868
[TBL] [Abstract][Full Text] [Related]
65. The prevalence and impact of cervical spine pathologies in patients with nasopharyngeal carcinoma.
Yung CS; Leung DKC; Cheung JPY
Oral Oncol; 2019 Mar; 90():48-53. PubMed ID: 30846176
[TBL] [Abstract][Full Text] [Related]
66. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
67. Clinicopathologic Characteristics and Prognosis of Tongue Squamous Cell Carcinoma in Patients with and without a History of Radiation for Nasopharyngeal Carcinoma: A Matched Case-Control Study.
Zhang P; Zhang L; Liu H; Zhao L; Li Y; Shen JX; Liu Q; Liu MZ; Xi M
Cancer Res Treat; 2017 Jul; 49(3):695-705. PubMed ID: 27737535
[TBL] [Abstract][Full Text] [Related]
68. Cognitive function before and after intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: a prospective study.
Hsiao KY; Yeh SA; Chang CC; Tsai PC; Wu JM; Gau JS
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):722-6. PubMed ID: 20044217
[TBL] [Abstract][Full Text] [Related]
69. Long-term Outcomes Following Radiotherapy for Adolescent Patients With Nonmetastatic WHO Type III Nasopharyngeal Carcinoma.
Greenwalt JC; Indelicato DJ; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM
Am J Clin Oncol; 2016 Dec; 39(6):581-585. PubMed ID: 24937634
[TBL] [Abstract][Full Text] [Related]
70. Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma.
Cheung MC; Chan AS; Law SC; Chan JH; Tse VK
Cancer; 2003 Apr; 97(8):2019-26. PubMed ID: 12673733
[TBL] [Abstract][Full Text] [Related]
71. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Liu YP; Wen YH; Tang J; Wei Y; You R; Zhu XL; Li J; Chen L; Ling L; Zhang N; Zou X; Hua YJ; Chen YM; Chen L; Lu LX; Chen MY; Wen WP
Lancet Oncol; 2021 Mar; 22(3):381-390. PubMed ID: 33600761
[TBL] [Abstract][Full Text] [Related]
72. Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers.
Liu CH; Lin CY; Huang BS; Wei YC; Chang TY; Yeh CH; Sung PS; Jiang JL; Lin LY; Chang JT; Fan KH
Radiat Oncol; 2023 Sep; 18(1):155. PubMed ID: 37735389
[TBL] [Abstract][Full Text] [Related]
73. Risk of ocular complications following radiation therapy in patients with nasopharyngeal carcinoma.
Lin KT; Lee SY; Liu SC; Tsao CC; Hsu SD; Chien WC; Chung CH; Chang WK; Chen YW; Lin CS
Laryngoscope; 2020 May; 130(5):1270-1277. PubMed ID: 31441954
[TBL] [Abstract][Full Text] [Related]
74. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?
Jen YM; Lin YS; Su WF; Hsu WL; Hwang JM; Chao HL; Liu DW; Chen CM; Lin HY; Wu CJ; Chang LP; Shueng PW
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):14-22. PubMed ID: 12182970
[TBL] [Abstract][Full Text] [Related]
75. Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma.
Lin PJ; Twu CW; Liu YC; Lin TY; Wang WY; Lin JC
Head Neck; 2018 Jun; 40(6):1156-1163. PubMed ID: 29389048
[TBL] [Abstract][Full Text] [Related]
76. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
[TBL] [Abstract][Full Text] [Related]
77. Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Wei Z; Zhang Z; Luo J; Li N; Peng X
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1857-1864. PubMed ID: 31062162
[TBL] [Abstract][Full Text] [Related]
78. Cognitive function, mood, and sleep quality in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer: a prospective study.
Mo YL; Li L; Qin L; Zhu XD; Qu S; Liang X; Wei ZJ
Psychooncology; 2014 Oct; 23(10):1185-91. PubMed ID: 24729515
[TBL] [Abstract][Full Text] [Related]
79. The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.
Du T; Xiao J; Qiu Z; Wu K
PLoS One; 2019; 14(7):e0219611. PubMed ID: 31291379
[TBL] [Abstract][Full Text] [Related]
80. Causes of Death in Long-Term Nasopharyngeal Carcinoma Survivors.
Yang SP; Rao MY; Chen QS; Zhou P; Lian CL; Wu SG
Front Public Health; 2022; 10():912843. PubMed ID: 35875003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
